We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Toolkit for Reductive Amination in Drug Discovery

By Biotechdaily staff writers
Posted on 23 Jun 2003
A toolkit is designed to simplify the incorporation of reductive amination in chemical drug discovery.

Conventional product workup and purification for reductive amination can be time-consuming and inefficient. More...
In contrast, the resin-bound reagents and scavengers in the toolkit deliver high-purity products requiring only a simple filtration step for product purification. The format allows rapid comparison of pre-defined protocols to determine the best procedure for specific target compounds.

The resin-bound reductants in the toolkit include MP-triacetoxyborohydride and MP-cyanoborohydride. The toolkit is the product of Argonaut Technologies, Inc. (Foster City, CA, USA; www.argotech.com). The company notes that according to The Comprehensive Medicinal Drug Database, about 75% of all chemical drugs currently in development could utilize this reaction.

"Drug discovery and medicinal chemists need simpler access to the chemical compounds generated using this reaction class,” said Howard D. Goldstein, senior vice president of Argonaut Technologies. "Reductive amination is a powerful tool that's used routinely to generate structurally diverse drug candidates.”




Related Links:
Argonaut

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.